Commission Implementing Regulation (EU) 2026/2526 of 13 November 2026 cancelling the Union authorisation for the single biocidal product Manorapid express GEL in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2023/1106
Article 3
In force · version of Dec 6, 2026
The biocidal product ‘Manorapid express GEL’ shall no longer be made available on the market from 6 June 2027 and existing stocks of such biocidal product shall no longer be used from 6 December 2027.